compounded semaglutide fda enforcement 2025 news Novo Nordisk expands legal action to protect US patients from unsafe, non- FDA-approved "semaglutide" Patients struggle as compounded GLP-1

Common causes of stalled progress include insufficient protein intake leading to metabolic slowdown, inadequate hydration affecting metabolism, missed or inconsistent injection timing, stress and sleep deprivation interfering with hormonal balance, and reaching a dose ceiling where higher doses no longer produce proportional benefits

Weight loss: 3 to 8% of body weight over 3 to 6 months for users who respond

Table 9 provides dosing recommendations in the presence and absence of renal impairment

Wang Z, Thurmond DC

However, gastrointestinal side effects such as nausea, vomiting, and diarrhoea may indirectly affect magnesium status through reduced intake or increased losses

No, the prescribing doctor is responsible for managing a medications side effects